[Pharmacological study on second-generation antipsychotic agents and the effects on improvement of cognitive function in patients with schizophrenia].
Kuroki
Toshihide
T
D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology* / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology; D004298:Dopamine / Q000378:metabolism; D015195:Drug Design; D005625:Frontal Lobe / Q000378:metabolism; D006801:Humans; D011976:Receptors, Muscarinic; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*
D018687:Antidepressive Agents, Second-Generation; D011976:Receptors, Muscarinic; D004298:Dopamine